Upgrade to SI Premium - Free Trial

Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 17c

November 5, 2020 5:21 PM

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.13), $0.17 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $7.05 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Categories

Earnings

Next Articles